10-Q: AmeriCann Inc. Reports Q3 2024 Results with Revenue Decline and Lease Termination

AmeriCann Inc. experienced a decrease in revenue and a net loss for the third quarter of 2024, primarily due to a lease modification and the upcoming termination of a key lease agreement.

Summary

• AmeriCann Inc. reported a net loss of $796,296 for the nine months ended June 30, 2024, compared to a net income of $53,442 for the same period in 2023.
• The company's revenue decreased to $1,102,047 for the nine months ended June 30, 2024, from $2,066,053 in the prior year, due to a lease modification.
• Operating expenses increased slightly to $1,519,385 for the nine months ended June 30, 2024, compared to $1,446,701 in 2023.
• The company's cash and cash equivalents decreased significantly to $210,640 as of June 30, 2024, from $1,135,006 as of September 30, 2023.
• A key lease agreement with BASK is set to terminate on August 31, 2024, after which AmeriCann intends to operate the building as a regulated cannabis cultivation and manufacturing operator.
• AmeriCann has an outstanding note payable of $4,500,000 with an unrelated party, secured by a first lien on Building 1 at the Massachusetts Cannabis Center (MCC).
• The company's accumulated deficit increased to $20,649,740 as of June 30, 2024, from $19,853,444 as of September 30, 2023.

Sentiment

Score: 3

Explanation: The document indicates a significant downturn in financial performance, a key lease termination, and a need for additional funding, which are all negative indicators for investors. The company's transition to operating the facility itself introduces additional risks and uncertainties.

Positives

• AmeriCann has secured two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support.
• The company plans to operate in Building 2 at the MCC, expanding its operations.
• AmeriCann has the option to purchase furniture and equipment from BASK after the lease termination.
• The company is exploring opportunities to replicate its brands, technology, and innovations in additional markets.

Negatives

• The company experienced a significant decrease in revenue and a net loss for the nine months ended June 30, 2024.
• The termination of the lease with BASK will require AmeriCann to transition to operating the facility itself.
• The company's cash position has significantly decreased.
• AmeriCann has a substantial accumulated deficit of $20,649,740.
• The company's disclosure controls and procedures were deemed not effective due to material weaknesses in internal control over financial reporting.

Risks

• The company's ability to continue as a going concern is dependent on its ability to generate additional revenues and raise additional funds.
• The termination of the lease with BASK introduces operational and financial risks.
• The company faces challenges in remediating material weaknesses in its internal control over financial reporting.
• There is no assurance that the company will be able to successfully operate the facility after the lease termination.
• The company may face difficulties in securing additional funding for expansion of the MCC.

Future Outlook

AmeriCann intends to operate Building 1 at the MCC as a regulated cannabis cultivation and manufacturing operator after the lease with BASK terminates on August 31, 2024. The company plans to expand operations in Building 2 and may replicate its brands and technology in other markets. The company will need to raise additional funds for the expansion of the MCC.

Management Comments

• Management believes that the actions presently being taken to further implement its business plan and generate additional revenues provide the opportunity for the Company to continue as a going concern.
• Management may raise additional funds through the sale of its securities or borrowings from third parties.

Industry Context

The cannabis industry is experiencing growth, but companies like AmeriCann face challenges in securing funding and managing operational transitions. The termination of the lease with BASK and the company's intention to operate the facility themselves reflects a trend of companies seeking greater control over their operations and revenue streams. The company's focus on large-scale extraction and branded consumer goods aligns with the industry's move towards more sophisticated product offerings.

Comparison to Industry Standards

• Compared to other cannabis companies, AmeriCann's revenue decline and net loss are concerning, especially given the growth in the broader industry.
• Companies like Curaleaf and Trulieve, which are vertically integrated, have shown more robust revenue growth and profitability, indicating that AmeriCann needs to improve its operational efficiency and revenue generation.
• The transition from a landlord to an operator is a significant shift, and AmeriCann's success will depend on its ability to manage cultivation and manufacturing effectively, similar to companies like Cresco Labs and Green Thumb Industries.
• The company's reliance on a single facility and a single tenant highlights a lack of diversification, which is a risk compared to companies with multiple facilities and revenue streams.

Related Party Transactions

• The company leases its office space from Strategic Capital Partners, LLC (SCP), a related party.
• The company incurred consulting expenses with SCP and paid $150,000 during the nine months ended June 30, 2024.
• The company has a note payable to SCP with an outstanding principal of $581,646.

Stakeholder Impact

• Shareholders face increased risk due to the company's net loss, decreased revenue, and need for additional funding.
• Employees may experience uncertainty due to the operational transition and financial challenges.
• Customers of BASK may be impacted by the lease termination and the transition to AmeriCann operating the facility.
• Suppliers may face uncertainty due to the company's financial challenges and operational changes.
• Creditors face increased risk due to the company's financial difficulties and accumulated deficit.

Next Steps

• AmeriCann will transition to operating Building 1 at the MCC after the lease termination on August 31, 2024.
• The company will seek approval from the Massachusetts Cannabis Control Commission for the transfer of licenses from BASK.
• A third-party valuation of furniture and equipment to be purchased from BASK is expected by the end of August 2024.
• AmeriCann will explore opportunities to expand operations in Building 2 at the MCC.
• The company will need to raise additional funds for the expansion of the MCC.

Key Dates

Keywords

cannabis, cultivation, manufacturing, lease, revenue, Massachusetts Cannabis Center, financial results, AmeriCann, MCC, BASK